Press Release

Changes of Representative Directors and Directors

Tokyo, April 27, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "the Company" ) today announced that at a meeting of its Board of Directors held today, it decided changes of Representative Directors and Directors as stated below. These changes are subject to approval at the Ordinary General Meeting of Shareholders to be held on June 19, 2017 and decision at the Board of Directors meeting scheduled for the same day.

  1. Changes of Representative Directors (New Representative Director candidate)

    Kenji Yasukawa

    (New) Representative Director, Executive Vice President

    (Current) Senior Corporate Executive, Senior Vice President, CSTO & CCO

    CSTO: Chief Strategy Officer CCO: Chief Commercial Officer

    (Representative Director to be retired)

    Yoshirou Miyokawa

    (Current) Representative Director, Executive Vice President

    • Effective date of changes: June 19, 2017

    • Reason for changes: Those changes are decided in order to pursue Astellas' growth strategies more vigorously by new leader.

      1

      • Curriculum Vitae of new Representative Director candidate

      Name: Kenji Yasukawa Date of Birth: June 7, 1960 Place of Birth: Tokyo

      -Education

      March 1986 University of Tokyo, Master of Science, Agriculture July 2001 Showa University Graduate School of Pharmaceutical

      Sciences, Japan, Ph.D. in Pharmaceutical Sciences

      -Carrier History

      April 1986 Joined the Company (former Yamanouchi Pharmaceutical Co., Ltd.)

      April 2005 Vice President, Project Management, Urology, the Company June 2010 Corporate Executive of the Company, Therapeutic Area Head,

      Urology, Astellas Pharma Europe B.V.

      October 2010 Corporate Executive of the Company, Therapeutic Area Head, Urology, Astellas Pharma Global Development, Inc.

      April 2011 Corporate Executive, Vice President,

      Product & Portfolio Strategy, the Company

      April 2012 Corporate Executive, Senior Vice President and Chief Strategy Officer, the Company

      June 2012 Senior Corporate Executive, Senior Vice President and Chief Strategy Officer, the Company

      April 2017 Senior Corporate Executive, Senior Vice President, Chief Strategy Officer and Chief Commercial Officer, the Company

      Ownership of shares: 11,315 shares (as of March 31, 2017)

  2. New Candidates of Directors

    Director Kenji Yasukawa

    Outside Director Mamoru Sekiyama

    Outside Director Keiko Yamagami

  3. Directors to be retired

Director Yoshirou Miyokawa

Outside Director Yutaka Kase

Outside Director Hironobu Yasuda

(Reference)

Curriculum Vitae of new Director candidates Name: Mamoru Sekiyama

Date of Birth: August 14, 1949

-Carrier History

April 1974 Joined Marubeni Corporation

April 1997 General Manager, Power Project Dept.-I, Marubeni Corporation April 1998 General Manager, Power Project Dept.-III, Marubeni Corporation April 1999 Deputy General Manager, Power Project Div.; General Manager,

Power Project Dept. I, Marubeni Corporation

April 2001 Senior Operating Officer, Utility Infrastructure Div.; General Manager, Overseas Power Project Dept., Marubeni Corporation

April 2002 Corporate Vice President, Chief Operating Officer, Plant, Power & Infrastructure Div., Marubeni Corporation

April 2005 Corporate Senior Vice President, Chief Operating Officer, Plant, Power & Infrastructure Projects Div., Marubeni Corporation

June 2006 Corporate Senior Vice President, Member of the Board, Marubeni Corporation

April 2007 Corporate Executive Vice President, Member of the Board, Marubeni Corporation

April 2009 Senior Executive Vice President, Member of the Board, Marubeni Corporation

April 2013 Vice Chairman, Marubeni Corporation

April 2015 Corporate Adviser, Marubeni Corporation (present post) Chairman, Marubeni Power Systems Corporation

Astellas Pharma Inc. published this content on 27 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 April 2017 03:07:11 UTC.

Original documenthttps://www.astellas.com/en/corporate/news/pdf/170427_Eg_3-2.pdf

Public permalinkhttp://www.publicnow.com/view/E88E4680DE908DC92F48E9B85440A54CB8F596C5